Overview
NICE is unable to recommend the use in the NHS of methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care. his is because TMC Pharma Services did not provide an evidence submission.
Last reviewed: 27 March 2013
Next review: We will review this decision if the company decides to make a submission.